Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
Authors
Keywords
Stroke, Ischemic stroke, Etiology, Medical risk factors, Anticoagulants, Renal system, Anticoagulant therapy, Cerebral ischemia
Journal
PLoS One
Volume 14, Issue 3, Pages e0213379
Publisher
Public Library of Science (PLoS)
Online
2019-03-30
DOI
10.1371/journal.pone.0213379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants
- (2018) J. C. Purrucker et al. ACTA NEUROLOGICA SCANDINAVICA
- Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
- (2018) David J. Seiffge et al. ANNALS OF NEUROLOGY
- Mechanical Thrombectomy in Patients with Acute Ischemic Stroke on Anticoagulation Therapy
- (2018) David Černík et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
- (2018) E. Touzé et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial
- (2018) Ilaria Cavallari et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non–Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
- (2018) Yukie Kanai et al. Journal of Stroke & Cerebrovascular Diseases
- Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
- (2018) Daniel Šaňák et al. Journal of Stroke & Cerebrovascular Diseases
- The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
- (2018) Yuji Kato et al. Journal of Stroke & Cerebrovascular Diseases
- Risk of Recurrent Ischemic Stroke with Unintended Low-Dose Oral Anticoagulant Therapy and Optimal Timing of Review
- (2018) Narihide Shinoda et al. Journal of Stroke & Cerebrovascular Diseases
- Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis
- (2018) Mingsu Liu et al. Journal of Stroke & Cerebrovascular Diseases
- Global Prospective Safety Analysis of Rivaroxaban
- (2018) Paulus Kirchhof et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke
- (2018) Carolin Hoyer et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non–Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
- (2018) Yukie Kanai et al. Journal of Stroke & Cerebrovascular Diseases
- Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
- (2018) Daniel Šaňák et al. Journal of Stroke & Cerebrovascular Diseases
- The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
- (2018) Yuji Kato et al. Journal of Stroke & Cerebrovascular Diseases
- Risk of Recurrent Ischemic Stroke with Unintended Low-Dose Oral Anticoagulant Therapy and Optimal Timing of Review
- (2018) Narihide Shinoda et al. Journal of Stroke & Cerebrovascular Diseases
- Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis
- (2018) Mingsu Liu et al. Journal of Stroke & Cerebrovascular Diseases
- Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
- (2018) Hee Tae Yu et al. STROKE
- Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non–Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
- (2018) Chen Jin et al. STROKE
- The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation
- (2017) Y. Sakamoto et al. EUROPEAN JOURNAL OF NEUROLOGY
- Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures
- (2017) Ovidiu Vornicu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection
- (2017) Pawel Kermer et al. International Journal of Stroke
- Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation
- (2017) Ying Xian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis
- (2017) Donna Kurowski et al. Journal of Stroke & Cerebrovascular Diseases
- Low risk of ICH after reperfusion therapy in acute stroke patients treated with direct oral anti-coagulant
- (2017) Kentaro Suzuki et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation
- (2017) Hyoshim Shin et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non–Vitamin K Antagonist Oral Anticoagulants
- (2017) Georgios Tsivgoulis et al. STROKE
- Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients
- (2017) Annemarie Bluecher et al. THROMBOSIS AND HAEMOSTASIS
- Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis
- (2017) Donna Kurowski et al. Journal of Stroke & Cerebrovascular Diseases
- Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants
- (2017) Jan C. Purrucker et al. Journal of Stroke
- Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
- (2017) David J. Seiffge et al. Journal of Stroke
- Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study
- (2016) Martin J. O'Donnell et al. AMERICAN HEART JOURNAL
- Evidence Supporting Idarucizumab for the Reversal of Dabigatran
- (2016) Charles V. Pollack AMERICAN JOURNAL OF MEDICINE
- Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation
- (2016) Tony Antoniou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units
- (2016) Waltraud Pfeilschifter et al. CEREBROVASCULAR DISEASES
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke
- (2016) Mark J. Alberts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study
- (2016) Shoji Arihiro et al. International Journal of Stroke
- Dabigatran Plasma Levels in Acute Cerebrovascular Events
- (2016) Bastian Volbers et al. Journal of Stroke & Cerebrovascular Diseases
- Continuation of direct oral anticoagulants in the acute phase of ischemic stroke. A case series
- (2016) Manuel Cappellari et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke
- (2016) David J. Seiffge et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Coagulation Testing in Acute Ischemic Stroke Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Dabigatran Plasma Levels in Acute Cerebrovascular Events
- (2016) Bastian Volbers et al. Journal of Stroke & Cerebrovascular Diseases
- Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation
- (2016) Christian T. Ruff et al. JAMA Cardiology
- Cognitive Impairment Is Not a Predictor of Failure to Adhere to Anticoagulation of Stroke Patients with Atrial Fibrillation
- (2015) Solveig Horstmann et al. CEREBROVASCULAR DISEASES
- Recanalization Therapies in Acute Ischemic Stroke PatientsCLINICAL PERSPECTIVES
- (2015) David J. Seiffge et al. CIRCULATION
- Non-vitamin K antagonist oral anticoagulants (NOAC): considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
- (2015) Hein Heidbuchel et al. EUROPACE
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation
- (2015) Qinmei Xiong et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinical Features of Ischemic Stroke during Treatment with Dabigatran: An Association between Decreased Severity and a Favorable Prognosis
- (2015) Takeshi Hayashi et al. INTERNAL MEDICINE
- Ischemic Stroke on Optimal Anticoagulation with Novel-Oral Anticoagulants Compared with Warfarin
- (2015) Bum Joon Kim et al. International Journal of Stroke
- Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants—Case Series and Systematic Review of Reported Cases
- (2015) Shima Shahjouei et al. Journal of Stroke & Cerebrovascular Diseases
- Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment
- (2015) Hirofumi Tomita et al. Journal of Stroke & Cerebrovascular Diseases
- Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation
- (2015) Letícia C. Rebello et al. STROKE
- Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants—Case Series and Systematic Review of Reported Cases
- (2015) Shima Shahjouei et al. Journal of Stroke & Cerebrovascular Diseases
- Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment
- (2015) Hirofumi Tomita et al. Journal of Stroke & Cerebrovascular Diseases
- 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
- (2014) Atul Verma et al. CANADIAN JOURNAL OF CARDIOLOGY
- Recombinant Tissue-type Plasminogen Activator (rt-PA) Therapy in an Acute Stroke Patient Taking Dabigatran Etexilate: A Case Report and Literature Review
- (2014) Emi Tabata et al. INTERNAL MEDICINE
- Proposed Approach to Thrombolysis in Dabigatran-Treated Patients Presenting with Ischemic Stroke
- (2014) Mahesh Kate et al. Journal of Stroke & Cerebrovascular Diseases
- Revascularization for Acute Ischemic Stroke Is Safe for Rivaroxaban Users
- (2014) Satoshi Kimura et al. Journal of Stroke & Cerebrovascular Diseases
- Presentation, therapy and outcome of patients with ischemic stroke under new oral anticoagulants
- (2014) Claudia Stöllberger et al. Neurologia i Neurochirurgia Polska
- The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping)
- (2013) P. Amarenco et al. CEREBROVASCULAR DISEASES
- Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
- (2013) T. Steiner et al. Clinical Research in Cardiology
- Treatment of Acute Stroke in Patients on Dabigatran: A Survey of US Stroke Specialists
- (2013) Igor Rybinnik et al. Journal of Stroke & Cerebrovascular Diseases
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
- (2012) Graeme J Hankey et al. LANCET NEUROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now